Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathy

被引:0
作者
Tomasz Bednarczuk
Lutz Schomburg
机构
[1] Medical University of Warsaw,Department of Internal Medicine and Endocrinology
[2] Charité-Universitätsmedizin Berlin,Institute for Experimental Endocrinology
来源
Hormones | 2020年 / 19卷
关键词
Graves’ disease; Graves’ orbitopathy; Selenium; Dietary supplements; Hyperthyroidism; Antithyroid drugs;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:31 / 39
页数:8
相关论文
共 142 条
[1]  
Liu J(2017)Antithyroid drug therapy for Graves’ disease and implications for recurrence Int J Endocrinol 2017 3813540-599
[2]  
Fu J(2011)The dilemma of how to manage Graves’ hyperthyroidism in patients with associated orbitopathy J Clin Endocr Metab 96 592-331
[3]  
Xu Y(2019)Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for Graves’ hyperthyroidism: a long-term follow-up with the thyroid-related patient-reported outcome questionnaire and 36-item short form health status survey Thyroid 29 322-R252
[4]  
Wang G(2014)Mechanisms in endocrinology: autoimmune thyroid disease: old and new players Eur J Endocrinol 170 R241-726
[5]  
Bartalena L(2015)The role of iodine and selenium in autoimmune thyroiditis Horm Metab Res 47 721-44
[6]  
Torring O(2019)Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease Proc Nutr Soc 78 34-1246
[7]  
Watt T(2008)On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health Mol Nutr Food Res 52 1235-465
[8]  
Sjolin G(2017)The role of selenium in thyroid gland pathophysiology Endokrynol Pol 68 440-20
[9]  
Effraimidis G(2013)Role of oxidative stress and selenium in Graves’ hyperthyroidism and orbitopathy J Endocrinol Investig 36 15-5188
[10]  
Wiersinga WM(2010)Selenium and the thyroid: a close-knit connection J Clin Endocrinol Metab 95 5180-171